153 related articles for article (PubMed ID: 26475066)
1. Optimizing Radiation Therapy Quality Assurance in Clinical Trials: A TROG 08.03 RAVES Substudy.
Trada Y; Kneebone A; Paneghel A; Pearse M; Sidhom M; Tang C; Wiltshire K; Haworth A; Fraser-Browne C; Martin J
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1045-51. PubMed ID: 26475066
[TBL] [Abstract][Full Text] [Related]
2. Contour variation is a primary source of error when delivering post prostatectomy radiotherapy: Results of the Trans-Tasman Radiation Oncology Group 08.03 Radiotherapy Adjuvant Versus Early Salvage (RAVES) benchmarking exercise.
Cloak K; Jameson MG; Paneghel A; Wiltshire K; Kneebone A; Pearse M; Sidhom M; Tang C; Fraser-Browne C; Holloway LC; Haworth A
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):390-398. PubMed ID: 30950223
[TBL] [Abstract][Full Text] [Related]
3. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10.
Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722
[TBL] [Abstract][Full Text] [Related]
4. A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.
Pearse M; Fraser-Browne C; Davis ID; Duchesne GM; Fisher R; Frydenberg M; Haworth A; Jose C; Joseph DJ; Lim TS; Matthews J; Millar J; Sidhom M; Spry NA; Tang CI; Turner S; Williams SG; Wiltshire K; Woo HH; Kneebone A
BJU Int; 2014 Mar; 113 Suppl 2():7-12. PubMed ID: 24894850
[TBL] [Abstract][Full Text] [Related]
5. Prostate radiotherapy clinical trial quality assurance: how real should real time review be? (A TROG-OCOG Intergroup Project).
Martin J; Frantzis J; Chung P; Langah I; Crain M; Cornes D; Plank A; Finch T; Jones M; Khoo E; Catton C
Radiother Oncol; 2013 Jun; 107(3):333-8. PubMed ID: 23751377
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Radiation Therapy Quality Assurance in NRG Oncology RTOG 0848.
Tchelebi LT; Winter KA; Abrams RA; Safran HP; Regine WF; McNulty S; Wu A; Du KL; Seaward SA; Bian SX; Aljumaily R; Shivnani A; Knoble JL; Crocenzi TS; DiPetrillo TA; Roof KS; Crane CH; Goodman KA
Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):107-114. PubMed ID: 37598723
[TBL] [Abstract][Full Text] [Related]
7. Successful implementation of image-guided radiation therapy quality assurance in the Trans Tasman Radiation Oncology Group 08.01 PROFIT Study.
Middleton M; Frantzis J; Healy B; Jones M; Murry R; Kron T; Plank A; Catton C; Martin J
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1576-81. PubMed ID: 21074334
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
[TBL] [Abstract][Full Text] [Related]
9. Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial.
Kearvell R; Haworth A; Ebert MA; Murray J; Hooton B; Richardson S; Joseph DJ; Lamb D; Spry NA; Duchesne G; Denham JW
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):247-57. PubMed ID: 23551788
[TBL] [Abstract][Full Text] [Related]
10. Technological advancements and error rates in radiation therapy delivery.
Margalit DN; Chen YH; Catalano PJ; Heckman K; Vivenzio T; Nissen K; Wolfsberger LD; Cormack RA; Mauch P; Ng AK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e673-9. PubMed ID: 21669503
[TBL] [Abstract][Full Text] [Related]
11. Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: are the results reflected in observed toxicity rates?
Ebert MA; Bulsara M; Haworth A; Kearvell R; Richardson S; Kennedy A; Spry NA; Bydder SA; Joseph DJ; Denham JW
J Med Imaging Radiat Oncol; 2015 Feb; 59(1):99-108. PubMed ID: 25082363
[TBL] [Abstract][Full Text] [Related]
12. Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.
Showalter TN; Ohri N; Teti KG; Foley KA; Keith SW; Trabulsi EJ; Lallas CD; Dicker AP; Hoffman-Censits J; Pizzi LT; Gomella LG
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e233-8. PubMed ID: 21605945
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.
Thompson IM; Valicenti RK; Albertsen P; Davis BJ; Goldenberg SL; Hahn C; Klein E; Michalski J; Roach M; Sartor O; Wolf JS; Faraday MM
J Urol; 2013 Aug; 190(2):441-9. PubMed ID: 23707439
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant versus salvage radiotherapy following radical prostatectomy: do the AUA/ASTRO guidelines have all the answers?
Su MZ; Kneebone AB; Woo HH
Expert Rev Anticancer Ther; 2014 Nov; 14(11):1265-70. PubMed ID: 25367321
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Failure Observed in the 2-Step Institution Credentialing Process for NRG Oncology/Radiation Therapy Oncology Group 1005 (NCT01349322) and Lessons Learned.
Li XA; Moughan J; White JR; Freedman GM; Arthur DW; Galvin J; Xiao Y; McNulty S; Lyons JA; Kavadi VS; Fields MT; Mitchell MP; Anderson BM; Lock MI; Kokeny KE; Bazan JG; Currey AD; Hijal T; Cheston SB; Vicini FA
Pract Radiat Oncol; 2020; 10(4):265-273. PubMed ID: 31790823
[TBL] [Abstract][Full Text] [Related]
16. A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer.
Ost P; De Troyer B; Fonteyne V; Oosterlinck W; De Meerleer G
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1316-22. PubMed ID: 20675081
[TBL] [Abstract][Full Text] [Related]
17. Implementing intensity modulated radiotherapy to the prostate bed: dosimetric study and early clinical results.
Riou O; Laliberté B; Azria D; Menkarios C; Llacer Moscardo C; Dubois JB; Aillères N; Fenoglietto P
Med Dosim; 2013; 38(2):117-21. PubMed ID: 23237661
[TBL] [Abstract][Full Text] [Related]
18. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
[TBL] [Abstract][Full Text] [Related]
19. Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedure.
Fenton PA; Hurkmans C; Gulyban A; van der Leer J; Matzinger O; Poortmans P; Collette L; Bolla M
Radiother Oncol; 2013 Jun; 107(3):346-51. PubMed ID: 23707151
[TBL] [Abstract][Full Text] [Related]
20. The quality assurance process for the ARTSCAN head and neck study - a practical interactive approach for QA in 3DCRT and IMRT.
Johansson KA; Nilsson P; Zackrisson B; Ohlson B; Kjellén E; Mercke C; Alvarez-Fonseca M; Billström A; Björk-Eriksson T; Björ O; Ekberg L; Friesland S; Karlsson M; Lagerlund M; Lundkvist L; Löfroth PO; Löfvander-Thapper K; Nilsson A; Nyman J; Persson E; Reizenstein J; Rosenbrand HO; Wiklund F; Wittgren L
Radiother Oncol; 2008 May; 87(2):290-9. PubMed ID: 18206256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
